UPMC Physician Resources
Regional Perfusion in the Treatment of Patients with Metastatic Melanoma
Dr. James F. Pingpank discusses the utility of regional perfusion strategies in the treatment of patients with metastatic melanoma.
Upon completion of this activity, participants should be able to:
- Describe the role of regional therapy for the management of hepatic metastases for ocular melanoma
- List risk factors present in primary tumors leading to the development of hepatic tumors
- Describe the role of immunotherapy for metastatic ocular melanoma
- Alexander HR, et al. J Clin Oncol. 2010 Jan 1;28(1):114-8.
- Avital I, et al. Ann Surg Oncol. 2010, 17(1):163-70.
- Zeh HJ, Bartlett DL. Ann Surg Oncol 2009; 16:385-94.
Dr. Pingpank has no relationships with proprietary entities producing health care goods or services.
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to 0.75 contact hour.
For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.
Release Date: 3/5/2013 | Last Modified On: 3/5/2013 | Expires: 3/5/2014